Fennec Pharmaceuticals Inc (FENC) — Cash Flow Reinvestment Rate

Latest as of March 2026: 0.00x

Fennec Pharmaceuticals Inc (FENC) has a Cash Flow Reinvestment Rate of 0.00x as of March 2026, reinvesting $1.00 (capex $1.00 ) from operating cash flow of $2.38 Million. Check how high is Fennec Pharmaceuticals Inc's earnings quality to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

$1.00
Capex + Investments

Operating Cash Flow

$2.38 Million
USD

Capital Expenditures

$1.00
USD

Fennec Pharmaceuticals Inc Cash Flow Reinvestment Rate (2024–2024)

Historical reinvestment intensity for Fennec Pharmaceuticals Inc across 1 annual periods. Explore FENC operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Fennec Pharmaceuticals Inc (2024–2024)

Year-by-year capital reinvestment analysis for Fennec Pharmaceuticals Inc. For live market cap and broader valuation context, see Fennec Pharmaceuticals Inc market cap and net worth.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2024 0.00x $0.00 $26.98 Million $0.00
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow